Neil Woodford’s asset management company sold its stake in Malin.

US hedge fund Pentwater Capital has emerged as the buyer of the 23 per cent stake in Irish life science investment company Malin Corp that was sold in(...)

Life sciences company Malin is focused on four priority assets. Photograph: iStock

Troubled UK asset manager Woodford Investment Management sold its remaining 3.5 per cent stake in Irish life sciences company Malin this week, accordi(...)

Neil Woodford, known as  the ‘Oracle from Oxford. Photograph: Richard Cannon

For long-suffering investors in Irish life-sciences investment company Malin, having once-revered UK stock picker Neil Woodford in their corner helped(...)

Malin was the subject of a board and management overhaul in the middle of last year that led to a refocusing of its disparate portfolio of investments around four priority assets

Irish life sciences investment company Malin Corp, whose shares have plunged in recent months amid fears over the future of embattled Woodford Investm(...)

Photograph: iStock

Life sciences investment company Malin Corp said on Tuesday that its chief business and financial officer Darragh Lyons has been appointed group chief(...)

Kymab’s main product is a potential treatment for eczema that is going through clinical trials. Photograph: iStock

One of Dublin-listed life science investment company Malin’s key holdings has signalled it plans to float on the stock market in the US. Biopharmaceu(...)

Ian Curley is a veteran of both Ardagh and Smurfit Kappa. Photograph: Dara Mac Dónaill

Life sciences investment company Malin’s chairman of less than a year, Ian Curley, has signalled that he plans to step down from the board as the busi(...)

Malin’s investee company Poseida Therapeutics has filed for a potential IPO.

Life sciences investment company Malin said on Monday that its investee company Poseida Therapeutics has filed for a potential initial public offering(...)

Malin has recently had a board and management overhaul and is now headed by Ian Curley. Photograph:  Dara Mac Donaill

Life sciences investment firm Malin Corporation, which has seen its share price tumble as much as 60 per cent since its 2015 flotation, has pledged to(...)

Ian Curley and other executives are  due to present details of the group’s review at a capital markets day in London early next month

Dublin-listed life sciences investment firm Malin has announced the departure of chief executive Adrian Howd after just one year in the post. The tro(...)

  • 1
  • 2
  • Next
  • Last »